[Immunomodulating properties of Acnevac vaccine].
The influence of Acnevac vaccine on immune responses of CBA mice was tested. Acnevac, the vaccine used in a treatment of patient with acne vulgaris, was produced by a Cracow Sera and Vaccines Manufacturer from cultures of Propionibacteria-strains. It was shown that Acnevac has strong immunomodulatory properties. It strongly stimulates humoral responses, has moderate effect on cell-mediated immune responses and it also activates peritoneal macrophages to release TNF-alpha.
Marcinkiewicz
J
J
Katedra Immunologii AM Krakowie.
Bryniarski
K
K
Nowak
B
B
Dzielska
D
D
Payerhin
F
F
D000152:Acne Vulgaris / Q000276:immunology / Q000628:therapy*; D000818:Animals; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000276:immunology*; D004195:Disease Models, Animal; D007167:Immunotherapy / Q000379:methods*; D008264:Macrophages / Q000276:immunology; D051379:Mice; D008808:Mice, Inbred CBA; D011044:Poland; D011424:Propionibacterium / Q000276:immunology*; D011425:Propionibacterium acnes / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*; D014612:Vaccines / Q000008:administration & dosage / Q000276:immunology*
C076288:Acnevac; D001428:Bacterial Vaccines; D014612:Vaccines
Immunomodulacyjne właściwości szczepionki Acnevac.